Literature DB >> 10477834

Use of older donor livers is associated with more extensive ischemic damage on intraoperative biopsies during liver transplantation.

M Deschênes1, C Forbes, J Tchervenkov, J Barkun, P Metrakos, J Tector, E Alpert.   

Abstract

Initial poor graft function is associated with increased morbidity and graft loss after liver transplantation. Donor age is a risk factor for the development of initial poor function. The severity of ischemic damage on intraoperative postreperfusion (0Post) allograft biopsy specimens is predictive of subsequent initial poor function. This study was performed to assess whether donor age is a risk factor for the development of ischemic damage on 0Post biopsy specimens. The records of 94 liver transplantations were reviewed. 0Post biopsy specimens were obtained after complete allograft revascularization. The severity of ischemic damage was graded as follows: 0, none; 1, minimal; 2, mild; 3, moderate; and 4, severe. Grafts were defined as older when donor age was 50 years or older. Other independent variables examined included donor cause of death, length of hospital stay, acidosis, serum alanine aminotransferase level, graft cold ischemia time, and degree of steatosis. Older grafts were associated with higher grades of ischemic damage than younger grafts (2.3 +/- 1.0 v 1.3 +/- 1.1; P =.003). Univariate and multivariate analysis identified donor age of 50 years or older as the only significant predictive variable of the severity of ischemic damage. In 16 transplantations involving older grafts, there was no statistically significant association between the severity of ischemic damage and incidence of initial poor function and graft loss. The use of older liver grafts is associated with more extensive ischemic damage immediately after graft reperfusion. Whether this early lesion identifies among older graft recipients those at risk for a worst outcome remains to be determined.

Entities:  

Mesh:

Year:  1999        PMID: 10477834     DOI: 10.1002/lt.500050501

Source DB:  PubMed          Journal:  Liver Transpl Surg        ISSN: 1074-3022


  7 in total

1.  Heme oxygenase-1 alleviates ischemia/reperfusion injury in aged liver.

Authors:  Xue-Hao Wang; Ke Wang; Feng Zhang; Xiang-Cheng Li; Jun Li; Wei De; Jun Guo; Xiao-Feng Qian; Ye Fan
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

2.  Heme oxygenase-1 regulates sirtuin-1-autophagy pathway in liver transplantation: From mouse to human.

Authors:  Kojiro Nakamura; Shoichi Kageyama; Shi Yue; Jing Huang; Takehiro Fujii; Bibo Ke; Rebecca A Sosa; Elaine F Reed; Nakul Datta; Ali Zarrinpar; Ronald W Busuttil; Jerzy W Kupiec-Weglinski
Journal:  Am J Transplant       Date:  2017-12-18       Impact factor: 8.086

3.  Liver grafts from selected older donors do not have significantly more ischaemia reperfusion injury.

Authors:  Paulo N Martins; Sue Chang; Basant Mahadevapa; Ann-Britt Martins; Patricia Sheiner
Journal:  HPB (Oxford)       Date:  2011-03       Impact factor: 3.647

4.  Excellent long-term patient and graft survival are possible with appropriate use of livers from deceased septuagenarian and octogenarian donors.

Authors:  Marcio F Chedid; Charles B Rosen; Scott L Nyberg; Julie K Heimbach
Journal:  HPB (Oxford)       Date:  2014-01-28       Impact factor: 3.647

5.  Long-term results using old liver grafts for transplantation: sexagenerian versus liver donors older than 70 years.

Authors:  Carlos Jiménez-Romero; Marta Clemares-Lama; Alejandro Manrique-Municio; Alvaro García-Sesma; Jorge Calvo-Pulido; Enrique Moreno-González
Journal:  World J Surg       Date:  2013-09       Impact factor: 3.352

6.  Outcomes of living donor liver transplantation using elderly donors.

Authors:  Jae Hyun Han; Young Kyoung You; Gun Hyung Na; Eun Young Kim; Soo Ho Lee; Tae Ho Hong; Dong Goo Kim
Journal:  Ann Surg Treat Res       Date:  2014-03-25       Impact factor: 1.859

7.  Predictors of renal recovery in patients with pre-orthotopic liver transplant (OLT) renal dysfunction.

Authors:  Jose Iglesias; Elliot Frank; Sushil Mehandru; John M Davis; Jerrold S Levine
Journal:  BMC Nephrol       Date:  2013-07-13       Impact factor: 2.388

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.